The Zumi uterine manipulator is a disposable intrauterine device used during laparoscopic and robotic hysterectomies to position and angle the uterus from below while the surgeon operates from above. It belongs to a family of manipulators that includes the RUMI, V-Care, Humi, Hulka, and several reusable designs, all sharing the same basic purpose: giving the surgeon control over the uterus without needing an open incision. The Zumi has drawn particular attention in the context of endometrial cancer surgery, where any instrument placed inside the uterus raises fair questions about whether it might push cancer cells into surrounding tissue. The research on that front is more reassuring than many surgeons initially expected.
What a Uterine Manipulator Actually Does
During a total laparoscopic hysterectomy, the surgeon works through small abdominal incisions using a camera and long instruments. The uterus, sitting deep in the pelvis, needs to be moved around so the surgeon can see and cut the ligaments, blood vessels, and tissue holding it in place. A uterine manipulator is inserted through the vagina and cervix before the laparoscopic portion begins, and an assistant at the foot of the table tilts and rotates the device throughout the procedure. This achieves maximum mobility of the uterus, improving the surgeon’s view and making dissection easier.1Human Reproduction Open. Recommendations for the surgical treatment of endometriosis. Part 2: deep endometriosis
One of the most critical moments comes during the colpotomy, when the surgeon cuts around the top of the vagina to separate the cervix. A manipulator fitted with a colpotomizer cup, a flared ring that sits at the junction of the cervix and vagina, gives the surgeon a visible landmark to cut along. Without that cup, identifying exactly where the cervix ends and the vagina begins can be tricky under a laparoscopic camera. Manipulators with this feature provide clear delineation of the cervicovaginal canal while allowing easier movement of the uterus.2Proceedings of the International Symposium on Human Factors and Ergonomics in Health Care. How Do Surgeon Preferences and Technique Variances Affect Outcome?
How Different Manipulators Compare
Surgeons have strong preferences about their manipulator of choice, and device selection often comes down to familiarity, institutional availability, and the specifics of the case. The Zumi is one of several disposable options, and head-to-head data directly comparing named brands against each other remain limited. Most comparative studies pit one or two specific devices against each other rather than testing the full lineup.
A randomized trial comparing the Clermont-Ferrand and Vectec manipulators during total laparoscopic hysterectomy found that the Vectec design led to shorter operating times, better visualization of the vaginal fornices, and superior maintenance of pneumoperitoneum (the gas pressure that inflates the abdomen during surgery).3PubMed. Clermont-Ferrand versus Vectec uterine manipulator for total laparoscopic hysterectomy Another randomized trial comparing two manipulators during laparoscopic hysterectomy found no difference in estimated blood loss between the devices.4PubMed. Comparing two Uterine Manipulators During Total Laparoscopic Hysterectomy: A Randomized Controlled Trial The pattern across the literature is that specific design features, such as the cup shape or the balloon mechanism, matter more for certain surgical steps than others, but overall outcomes like blood loss and complication rates tend to be similar.
One situation where device choice appears to make a measurable difference involves patients who have an intrauterine device (IUD) in place during endometriosis surgery. A study examining IUD displacement during uterine manipulation found that the RUMI manipulator was less likely to be associated with displacement than other manipulators.5Journal of Gynecologic Surgery. Risk of Intrauterine Device Displacement with Uterine Manipulation During Endometriosis Surgery This is a niche concern, but it matters to patients relying on their IUD for contraception who are undergoing surgery for a condition other than hysterectomy.
The Oncological Safety Question
The biggest controversy around uterine manipulators, including the Zumi, involves cancer surgery. When a patient has endometrial cancer, the standard treatment is hysterectomy with surgical staging. Placing a manipulator inside a uterus that contains a tumor raises a logical concern: could the device push malignant cells through the fallopian tubes into the peritoneal cavity, or drive them into lymphovascular spaces, worsening the prognosis?
This question has been studied intensively over the past decade, and the accumulated evidence is largely reassuring. A systematic review and meta-analysis pooling results from multiple studies found no significant difference in the rate of lymphovascular space invasion (LVSI) between hysterectomies performed with a manipulator and those performed without one, and no difference between manipulator-assisted minimally invasive surgery and open abdominal hysterectomy.6PubMed. Influence of uterine manipulator on oncological outcome in minimally invasive surgery of endometrial cancer: A systematic review and meta-analysis A propensity score-matched analysis similarly found that intrauterine manipulator use was not associated with higher rates of LVSI or positive peritoneal cytology, supporting the conclusion that manipulators do not significantly push malignant cells into the peritoneal cavity.7PubMed Central. Oncological Safety of Intrauterine Manipulator Use in Laparoscopic Hysterectomy for Endometrial Cancer: A Propensity Score-Matched Analysis
Work looking specifically at micrometastases and isolated tumor cells, which are the subtlest forms of cancer spread that can be detected in lymph nodes, has also been reassuring. In one analysis of 175 patients who underwent endometrial cancer surgery, uterine manipulation did not appear to be related to an increase in micrometastases or isolated tumor cells, regardless of the type of manipulator used, with devices including the Humi, Zumi, Hulka, and V-Care all examined.8PubMed Central. Role of uterine manipulator during laparoscopic endometrial cancer treatment This is one of the few published studies to name the Zumi specifically alongside other devices, and the results grouped together without showing any one brand as worse than another.
None of this means the concern was unfounded. The question was entirely reasonable, and early case series did suggest possible associations. But as larger and better-designed studies accumulated, the signal disappeared. Some oncologic surgeons still prefer to avoid a manipulator when operating on higher-grade or more advanced cancers, and that is a defensible choice. The data, however, do not support the idea that manipulator use systematically worsens recurrence or survival.
Complications Worth Knowing About
Uterine perforation is the most discussed complication of manipulator use. In a study of 82 patients undergoing minimally invasive endometrial cancer surgery, nine perforations occurred, a rate of about 11%. The type of manipulator used and whether the approach was laparoscopic or robotic did not influence whether perforation happened.9PubMed. Use of uterine manipulator and uterine perforation in minimally invasive endometrial cancer surgery That rate sounds high, and it is worth noting that the study focused specifically on cancer patients, whose uterine tissue may be more fragile or structurally compromised than in benign cases. In routine hysterectomies for non-cancerous conditions, perforation rates tend to be lower.
When perforation does happen, it usually results from one of two errors during setup: either the uterine length was measured incorrectly and a rod that was too long was inserted, or the uterus was inadvertently perforated during the initial sounding and the manipulator then followed the same false tract. A case report involving the Hohl manipulator described exactly this scenario, where a long rod extension perforated the uterus and penetrated the bowel.10PubMed Central. Iatrogenic uterine perforation and bowel penetration using a Hohlmanipulator: A case report The lesson from that case is that the complication was tied to improper use of the device rather than an inherent design flaw.
Balloon-tipped manipulators carry an additional risk if overinflated. Two reported cases of uterine rupture occurred when the intrauterine balloon of a RUMI manipulator was overinflated during chromopertubation, a procedure where dye is pushed through the fallopian tubes. One rupture happened at the uterine fundus and was simply sutured during surgery. The other occurred in the lateral uterine wall, caused a large retroperitoneal hematoma, and required a second operation.11PubMed. Iatrogenic uterine rupture caused by overinflation of RUMI manipulator balloon These reports are rare, but they underscore that the assistant handling the manipulator needs to follow inflation limits precisely.
When a Manipulator Cannot Be Placed
Not every patient’s anatomy allows for a uterine manipulator. A large cervical fibroid, for instance, can distort the cervical canal so completely that no device can be threaded through it. In those situations, surgeons have to improvise. One described approach involves applying traction directly to the uterus and cervix with a laparoscopic tenaculum, then placing a sponge stick in the anterior vaginal fornix to mark where the colpotomy should go.12Journal of Minimally Invasive Gynecology. Technical Considerations for Total Laparoscopic Hysterectomy for Large Cervical Fibroid Precluding Placement of Uterine Manipulator The surgery can still be completed laparoscopically, but it requires more skill and usually takes longer.
Previous cervical surgery, severe cervical stenosis, and certain congenital uterine anomalies can also make manipulator placement difficult or impossible. Some surgeons will attempt gentle dilation before giving up, while others will proceed without a manipulator if dilation risks perforating an already compromised cervix. The decision is case-by-case and depends on the surgeon’s comfort level with alternative techniques.
Use Beyond Gynecologic Surgery
Uterine manipulators are not limited to hysterectomy. They play a role in deep endometriosis surgery, where dense adhesions and nodules can distort pelvic anatomy to the point where the uterus, rectum, and ureters are difficult to distinguish from each other. Moving the uterus out of the way gives the surgeon space to identify and protect surrounding structures.13Human Reproduction Open. Recommendations for the surgical treatment of endometriosis. Part 2: deep endometriosis
An interesting recent application is in laparoscopic rectal cancer surgery. When a rectal tumor sits in the lower pelvis, the uterus can physically block the surgeon’s view and access. A study comparing laparoscopic rectal cancer cases with and without a uterine manipulator found that the manipulator group had no increase in bleeding or operative time. About 10% of patients in both groups lost more than 300 mL of blood, and average operative duration was essentially the same at roughly 150 minutes per case.14PubMed Central. The impact of uterine manipulator assistance on intraoperative exposure and outcomes in laparoscopic rectal cancer surgery The benefit was primarily in exposure, the surgeon’s ability to see the operative field clearly, rather than in measurable outcome metrics.
Cost and Environmental Impact
Uterine manipulators come in three basic categories: fully disposable (single-use), fully reusable (stainless steel, sterilized between cases), and hybrid designs that combine a reusable handle with disposable tips or cups. The Zumi falls into the disposable category, which has implications for long-term cost.
A lifecycle cost analysis comparing these three categories found that the fully reusable stainless-steel manipulator was the cheapest option over time. Over a simulated 300 cases, the hybrid design was more than $43,000 more expensive than the reusable one. Disposable options cost $16,000 to $26,000 more than the reusable device over the same period, depending on the specific product. It took roughly 25 to 45 uses for the reusable device to break even against disposable alternatives, and only about 10 uses to break even against the hybrid.15PubMed Central. A Comparative Carbon Footprint and Cost Analysis of Uterine Manipulators for Hysterectomy
The same analysis looked at carbon footprint, and the reusable device came out ahead there too. For a high-volume surgical center performing hundreds of hysterectomies a year, the financial and environmental case for reusable instruments is strong. The trade-off is convenience: disposable devices require no reprocessing, eliminate the risk of inadequate sterilization, and are ready to use out of the packaging. Smaller surgical centers that perform fewer hysterectomies may find the break-even point takes longer to reach, making disposable options more practical despite the higher per-case cost.
Training and the Role of the Assistant
Operating the uterine manipulator falls to the surgical assistant, who is often a medical student or junior resident on their gynecology rotation. The task sounds simple (push the uterus where the surgeon tells you), but doing it well requires understanding the anatomy, recognizing the limits of force, and responding smoothly to verbal cues during the operation. A clumsy assistant can obstruct the surgeon’s view, make the colpotomy more difficult, or contribute to a perforation.
A prospective study at the University of Vermont found that before receiving formal manipulator training, nearly 70% of third-year medical students reported feeling uncomfortable assisting with laparoscopic surgery. After a structured session that included a short video and hands-on practice with a low-fidelity pelvic trainer, more than 75% agreed that the training improved their ability to participate effectively, increased the educational value of the cases they observed, and enhanced their comfort in the operating room. Knowledge scores improved significantly between pre- and post-training assessments, and students scored an average of 91% on a technical skills evaluation at the end of the rotation.16PubMed Central. Enhancing the Gynecologic Surgery Experience for Third-Year Medical Students: The Impact of Formal Uterine Manipulator Training
The broader point from that study is that manipulator training is often treated as something students will just pick up on the job, which is how 70% of them end up feeling out of their depth. A short, deliberate training session makes a meaningful difference. Given that complications like perforation are closely tied to the skill and attentiveness of the person handling the manipulator, formalized training is not just about student comfort; it has safety implications for the patient.
Choosing Between Disposable and Reusable Designs
If you are a patient about to undergo a laparoscopic hysterectomy, you are unlikely to have a say in which manipulator your surgeon uses. The decision is driven by what the hospital stocks, what the surgeon trained on, and what the case demands. But understanding the trade-offs can help you ask better questions.
Disposable manipulators like the Zumi offer guaranteed sterility and consistent performance. There is no wear on the device, no joints that have loosened over years of use, and no risk that a reprocessing error left residual biofilm. For hospitals with lower surgical volumes or limited sterilization infrastructure, disposables can be the practical choice. The downside is cost per case and waste generation, both of which add up quickly at busy centers.
Reusable stainless-steel designs are cheaper in the long run and produce far less waste, but they require proper cleaning, inspection, and sterilization after every use. A worn or poorly maintained reusable instrument could theoretically perform worse, though no published study has documented that as a clinical problem. Hybrid designs attempt to split the difference by pairing a durable handle with disposable tips, but as the cost data show, they can end up being the most expensive option of all.
What the evidence consistently shows is that the skill of the surgical team matters more than which specific device is on the instrument tray. A well-trained assistant using any competently designed manipulator will achieve good visualization and safe tissue handling. A poorly trained assistant using the most expensive device on the market will not. For surgeons evaluating which manipulator to adopt, the most productive investment may not be a different brand of instrument but a structured training protocol for the people who will be holding it.